Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASSERT: Abacavir/Lamivudine vs Tenofovir/Emtricitabine in HIV
NCT00549198Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 4 trial of abacavir + lamivudine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by GSK. Started Jun 2007; status: completed.
02
Drugs
abacavir + lamivudine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00549198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549198.